Clinical Trial

Central Sensitisation in Nociceptive and Neuropathic Pain

Study acronym: ALGOS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate differences in central sensitization among patients with chronic nociceptive pain, neuropathic pain, and mixed pain conditions. Chronic pain is a complex and multidimensional phenomenon involving sensory, cognitive, emotional, and behavioral components, often sustained by mechanisms of central sensitization that contribute to pain persistence and treatment resistance. Using a multidimensional assessment approach, the study integrates self-report questionnaires, neuropsychological evaluation, psychological measures, treatment adherence assessment, and neurophysiological investigation through laser-evoked potentials (LEP). Participants will be evaluated at baseline and after 12 months to explore differences between pain types and longitudinal changes in central sensitization, cognitive functioning, emotional status, and engagement with treatment. The findings are expected to improve the understanding of neurobiological and psychosocial mechanisms underlying different chronic pain phenotypes and to support more personalized and effective pain management strategies.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-21
Trial Details
NCT Number NCT07321080
Lead Sponsor IRCCS Centro Neurolesi Bonino Pulejo
Conditions Chronic Pain, Nociceptive Pain, Neuropathic Pain, Mixed Pain (Nociceptive and Neuropathic)
Enrollment 185 participants
Start Date 2025-12-15
Primary Completion 2027-12-15 (estimated)
Study Completion 2027-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-20